CompletedNCT02323763
An fMRI Study on Temporal Discounting in Bipolarity
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
In BostonBipolarity, DepressionOtherFrom 18 Years to 65 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT00835107
An Investigation of Sleep Architecture in Ziprasidone-Treated Depression in bipolarity
This study is completed. It focuses on bipolarity and currently lists study information in Canada.
In KingstonBipolarity, DepressionDrugA study involving a medication or substance.Over 18 Years
CompletedNCT00520507
An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients
This study is completed. It focuses on depression and currently lists study information in Canada.
In KingstonDepression, BipolarityDrugOver 18 Years
CompletedNCT01498770
An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)
This study is completed. It focuses on bipolarity and currently lists study information in Global.
In GlobalBipolarityDrug
CompletedNCT01765127
An Observational Modified Prescription-event Monitoring Study of Asenapine (Sycrest)
This study is completed. It focuses on bipolarity and currently lists study information in the United Kingdom.
In SouthamptonBipolarityOther
CompletedNCT02640950
An Open Label study of TMS Therapy for Depression in bipolarity
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
Multiple locations, including BaltimoreBipolarity, DepressionDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
CompletedNCT00360126
An Extension Study Of Lamotrigine In Subjects With Bipolarity
This study is completed in Australia. It is testing lamotrigine for Bipolarity.
Multiple locations, including GreenwichBipolarityDrugOver 18 Years
CompletedNCT00238485
Licarbazepine 750-2000 mg/d for manic episodes in bipolarity type I
This study is completed in Global. It is testing Licarbazepine 750-2000 mg/d for manic episodes in bipolarity type I.
In GlobalBipolarityDrugFrom 18 Years to 70 Years
CompletedNCT00228059
Licarbazepine for manic episodes in bipolarity type I
This study is completed in the United States. It is testing licarbazepine for manic episodes in bipolarity type I.
In CerritosBipolarityDrugFrom 18 Years to 70 Years
Enrolling By InvitationNCT07217860
An Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
This study is enrolling by invitation in the United States. It is testing azetukalner for depression.
Multiple locations, including Little RockBipolarity, DepressionDrugFrom 18 Years to 75 Years
CompletedNCT06099132
Antagonist Activation Measurement at the Ankle Using High-density and Bipolar Surface EMG in Chronic Hemiparesis
This study is completed. It focuses on bipolarity and currently lists study information in Global.
In GlobalBipolarityDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.Over 18 Years
CompletedNCT00288366
Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome
This study is completed. It focuses on schizophrenia and currently lists study information in the United States.
In NashvilleSchizophrenia, BipolarityDrugFrom 18 Years to 65 Years